PUBLISHER: The Business Research Company | PRODUCT CODE: 1946561
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946561
Mobile ECG (electrocardiogram) devices are portable monitoring tools designed for capturing and assessing the electrical activity of the heart outside of clinical environments. These devices are characterized by their portability, lightweight design, and user-friendly features, making them well-suited for obtaining ECG readings either at home or while on the move. They serve as a comprehensive diagnostic approach for detecting arrhythmias, facilitating at-home heart monitoring, and providing complete disclosure of ECG signals, along with thorough data analysis and reporting.
Two main categories of mobile ECG devices exist, monitoring ECG systems and diagnostic ECG systems. Monitoring ECG systems are designed for rapid testing to assess the electrical activity and rhythm of the heart. These systems encompass various modalities, such as handheld, pen, band, and others, catering to a diverse range of end users. These end users include personal users, hospitals, clinics, and ambulatory services, highlighting the versatility and broad applicability of mobile ECG devices in different healthcare settings.
Tariffs are influencing the mobile ecg devices market by increasing costs of imported sensors, semiconductors, batteries, wireless communication modules, and electronic components. North America and Europe are most affected due to reliance on imported consumer-grade electronics and medical sensors, while Asia-Pacific faces higher costs for device exports. These tariffs are increasing device prices and impacting adoption among price-sensitive consumers. However, they are also encouraging local manufacturing, regional electronics sourcing, and innovation in cost-optimized portable cardiac monitoring solutions.
The mobile ecg devices market research report is one of a series of new reports from The Business Research Company that provides mobile ecg devices market statistics, including mobile ecg devices industry global market size, regional shares, competitors with a mobile ecg devices market share, detailed mobile ecg devices market segments, market trends and opportunities, and any further data you may need to thrive in the mobile ecg devices industry. This mobile ecg devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The mobile ecg devices market size has grown strongly in recent years. It will grow from $121.39 billion in 2025 to $131.1 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, growing adoption of home-based health monitoring, rising demand for non-invasive diagnostics, expansion of telehealth services, improved affordability of portable medical devices.
The mobile ecg devices market size is expected to see strong growth in the next few years. It will grow to $182.64 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing integration of ai-based cardiac analytics, rising demand for preventive cardiac care, expansion of remote patient monitoring programs, growing focus on personalized cardiac diagnostics, continuous advancements in sensor and wearable technologies. Major trends in the forecast period include increasing adoption of wearable ecg monitoring devices, rising use of smartphone-integrated ecg systems, growing demand for continuous remote cardiac monitoring, expansion of cloud-based ecg data analytics, enhanced focus on early arrhythmia detection.
The increasing prevalence of heart-related conditions is anticipated to drive the expansion of the mobile ECG devices market in the coming years. Heart-related conditions encompass a broad range of disorders affecting the heart and blood vessels, including coronary heart disease, congenital heart disease, and other cardiovascular abnormalities. Mobile electrocardiogram (ECG) devices are widely used for the diagnosis of myocardial infarction and cardiac arrhythmias, enabling more effective, continuous, and user-friendly monitoring of cardiac disorders. This helps reduce the number of undiagnosed, untreated, or inadequately monitored cases. For example, in October 2024, according to data published by the Centers for Disease Control and Prevention (CDC), a United States-based government agency, cardiovascular disease accounted for 919,032 deaths in the United States in 2023, representing approximately one in every three deaths. Consequently, the rising burden of heart-related conditions is contributing significantly to the growth of the mobile ECG devices market.
Leading companies operating in the mobile ECG devices market are increasingly concentrating on the development of advanced solutions, such as artificial intelligence (AI)-enabled handheld systems, to enhance the accuracy of real-time cardiac monitoring while improving patient convenience. AI-powered handheld systems are compact medical devices that leverage artificial intelligence to analyze cardiac data in real time and deliver rapid, reliable diagnostic insights. For instance, in July 2025, AliveCor Inc., a United States-based medical technology company, introduced its first-of-its-kind AI-powered Kardia 12-lead ECG system in India. The device features a distinctive single-cable design and is capable of identifying 35 cardiac conditions, including acute myocardial infarction and multiple types of arrhythmias. It is battery-operated, weighs approximately 135 grams, and is small enough to fit into a physician's lab coat pocket, making it highly portable. Additionally, the system requires minimal training, simplifies patient preparation by eliminating the need for full disrobing, and delivers fast, accurate diagnostic results comparable to those of conventional ECG machines.
In May 2024, WearLinq, Inc., a United States-based healthcare technology company, acquired AMI Cardiac Monitoring, LLC for an undisclosed consideration. Through this acquisition, WearLinq seeks to broaden its nationwide clinical service offerings and combine its United States Food and Drug Administration (FDA) 510(k)-cleared six-lead wearable ECG technology with AMI's established cardiac monitoring services. This strategic move is intended to improve patient access to remote cardiac diagnostics and strengthen the company's mobile ECG service capabilities. AMI Cardiac Monitoring, LLC is a United States-based healthcare technology company specializing in ambulatory cardiac monitoring services delivered through advanced mobile ECG devices.
Major companies operating in the mobile ecg devices market are Medtronic PLC, Koninklijke Philips N.V., GE Healthcare, Omron Corporation, Mindray Medical International Limited, ZOLL Medical Corporation, Nihon Kohden Corporation, Spacelabs Healthcare, Biotronik SE & Co KG, Fukuda Denshi Co. Ltd., Bittium Biosignals Ltd., Contec Medical Systems Co. Ltd., Schiller AG, Preventice Solutions Inc., BPL Medical Technologies Pvt. Ltd., AliveCor Inc., EB Neuro S.p.A, GETEMED Medical and Information, QT Medical Inc., Qardio Inc., Innomed Medical Inc., MD Biomedical Inc., CardioComm Solutions Inc., Hexoskin, VectraCor Inc., Cardiocity Limited
North America was the largest region in the mobile ECG devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mobile ecg devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the mobile ecg devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The mobile ECG device market consists of sales of wearable ECG devices, smartphone-connected ECG devices, and patch-based ECG devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Mobile ECG Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses mobile ecg devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for mobile ecg devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mobile ecg devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.